journal cover

Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry

European Journal of Clinical Pharmacology

Feb 1, 2008

Christoph Hiemke

Get paper from

Abstract

Based on the assumption that a relationship between blood levels and clinical effects (therapeutic effects, adverse events and toxicity) can be defined and considering that after equal doses plasma concentrations vary markedly between individual patients, therapeutic drug monitoring (TD...read more

Mentioned in this Paper

Cytochrome P450
Pharmacokinetic Aspects
Pharmacogenetics
Brain Diseases, Metabolic, Inborn
Drug-Induced Liver Injury
Clinical Trial [Publication Type]
Therapeutic Drug Monitoring
Diagnosis, Psychiatric
Historical Events,21st Century
Drug Kinetics
Paper Details
References
  • References56
  • Citations20
12345...
  • References56
  • Citations20
12

Similar Papers Found In These Feeds

Mechanisms of CYP450

Cytochrome P450 (CYP450) are a family of enzymes involved in two major processes, such as the synthesis of fatty acids, steroids, and biles acids, and the metabolism of toxins and drugs. Discover the latest research on the Mechanisms of CYP450 enzymes here.

Psychoactive Drugs

Psychoactive drugs are psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. Here is the latest research on psychoactive drugs and the pathways they modulate.

Drug-Induced Diseases

Drug-induced diseases (DID) also called as iatrogenic diseases. Most of these DIDs are largely preventable, if strict vigilance and proper periodic clinical and diagnostic monitoring are undertaken

Pharmacogenetics & Pharmacogenomics

Pharmacogenetics and pharmacogenomics (pgx) are rapidly growing fields that aim to elucidate the genetic basis for the interindividual differences in drug response. Here is the latest research on pharmacogenetics and pharmacogenomics.

© 2019 Meta ULC. All rights reserved

Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry

European Journal of Clinical Pharmacology

Feb 1, 2008

Christoph Hiemke

PMID: 18196227

DOI: 10.1007/s00228-007-0430-1

Abstract

Based on the assumption that a relationship between blood levels and clinical effects (therapeutic effects, adverse events and toxicity) can be defined and considering that after equal doses plasma concentrations vary markedly between individual patients, therapeutic drug monitoring (TD...read more

Mentioned in this Paper

Cytochrome P450
Pharmacokinetic Aspects
Pharmacogenetics
Brain Diseases, Metabolic, Inborn
Drug-Induced Liver Injury

Related Papers

Paper Details
References
  • References56
  • Citations20
12345...
  • References56
  • Citations20
12

Get paper from

/papers/clinical-utility-of-drug-measurement-and/18196227